Prostalund Ab Stock Profit Margin
PLUN Stock | SEK 8.40 0.60 6.67% |
ProstaLund AB fundamentals help investors to digest information that contributes to ProstaLund's financial success or failures. It also enables traders to predict the movement of ProstaLund Stock. The fundamental analysis module provides a way to measure ProstaLund's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ProstaLund stock.
ProstaLund |
ProstaLund AB Company Profit Margin Analysis
ProstaLund's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current ProstaLund Profit Margin | (0.61) % |
Most of ProstaLund's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ProstaLund AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, ProstaLund AB has a Profit Margin of -0.6072%. This is 94.58% lower than that of the Healthcare sector and significantly lower than that of the Medical Care Facilities industry. The profit margin for all Sweden stocks is 52.19% lower than that of the firm.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
All Next | Launch Module |
ProstaLund Fundamentals
Return On Equity | -0.25 | |||
Return On Asset | -0.13 | |||
Profit Margin | (0.61) % | |||
Operating Margin | (0.59) % | |||
Current Valuation | 215.81 M | |||
Shares Outstanding | 57.19 M | |||
Shares Owned By Insiders | 50.77 % | |||
Shares Owned By Institutions | 1.93 % | |||
Price To Book | 5.09 X | |||
Price To Sales | 13.54 X | |||
Revenue | 17.07 M | |||
Gross Profit | 14.68 M | |||
EBITDA | (7.54 M) | |||
Net Income | (7.88 M) | |||
Cash And Equivalents | 19.11 M | |||
Cash Per Share | 2.98 X | |||
Current Ratio | 6.11 X | |||
Book Value Per Share | 0.79 X | |||
Cash Flow From Operations | (5.8 M) | |||
Earnings Per Share | (0.17) X | |||
Beta | 0.84 | |||
Market Capitalization | 248.19 M | |||
Total Asset | 43.48 M | |||
Retained Earnings | 19 M | |||
Current Asset | 27 M | |||
Current Liabilities | 4 M | |||
Net Asset | 43.48 M |
About ProstaLund Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ProstaLund AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProstaLund using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProstaLund AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ProstaLund Stock Analysis
When running ProstaLund's price analysis, check to measure ProstaLund's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProstaLund is operating at the current time. Most of ProstaLund's value examination focuses on studying past and present price action to predict the probability of ProstaLund's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProstaLund's price. Additionally, you may evaluate how the addition of ProstaLund to your portfolios can decrease your overall portfolio volatility.